ImageneBio, Inc.
IMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001835579
In the last 90 days, ImageneBio, Inc. insiders filed 0 open-market purchases and 1 sale; 35 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in ImageneBio, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 57
- +4 vs. Q4 2023
- Shares held
- 30.1M
- −2.29M (−7.1%) vs. Q4 2023
- Total value
- $42.7M
- −$21.1M (−33.0%) vs. Q4 2023
- New holders
- 12
- 15 more added
- Sold out
- 8
- 17 more reduced
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 35 | $36.8M |
| Q1 2026 | 39 | $26.8M |
| Q4 2025 | 41 | $32.9M |
| Q3 2025 | 33 | $38.3M |
| Q2 2025 | 41 | $42.6M |
| Q1 2025 | 46 | $41.9M |
| Q4 2024 | 53 | $52.0M |
| Q3 2024 | 57 | $49.1M |
| Q2 2024 | 70 | $47.9M |
| Q1 2024 | 57 | $42.7M |
| Q4 2023 | 54 | $63.8M |
| Q3 2023 | 58 | $141.6M |
| Q2 2023 | 52 | $204.7M |
| Q1 2023 | 39 | $86.2M |
| Q4 2022 | 34 | $69.9M |
| Q3 2022 | 42 | $93.2M |
| Q2 2022 | 46 | $118.7M |
| Q1 2022 | 48 | $167.8M |
| Q4 2021 | 49 | $343.6M |
| Q3 2021 | 39 | $271.8M |
| Q2 2021 | 42 | $293.2M |
| Q1 2021 | 27 | $538.5M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding ImageneBio, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,018,178 | $7.13M | 0.66% | 00.0% | Unchanged |
| BVF Inc | 4,769,164 | $6.77M | 0.19% | 00.0% | Unchanged |
| Blue Owl Capital Holdings LP | 3,891,118 | $5.53M | 1.10% | +1,937,502+99.2% | Added |
| OrbiMed Advisors LLC | 3,539,358 | $5.03M | 0.10% | 00.0% | Unchanged |
| Omega Fund Management, LLC | 2,249,123 | $3.19M | 2.06% | 00.0% | Unchanged |
| BlackRock Inc. | 1,828,752 | $2.60M | 0.00% | −29,404−1.6% | Reduced |
| Vanguard Group Inc | 1,532,169 | $2.18M | 0.00% | +7,321+0.5% | Added |
| Verition Fund Management LLC | 1,134,687 | $1.61M | 0.02% | −187,710−14.2% | Reduced |
| Renaissance Technologies LLC | 776,600 | $1.10M | 0.00% | +776,600 | New |
| Geode Capital Management, LLC | 597,277 | $848.2K | 0.00% | +67,908+12.8% | Added |
| NEA Management Company, LLC | 570,050 | $809.5K | 0.05% | 00.0% | Unchanged |
| Jacobs Levy Equity Management, Inc | 513,440 | $729.1K | 0.00% | +457,245+813.7% | Added |
| State Street Corp | 482,645 | $685.4K | 0.00% | +71,900+17.5% | Added |
| Acuitas Investments, LLC | 397,746 | $564.8K | 0.28% | +397,746 | New |
| Sofinnova Investments, Inc. | 382,616 | $543.3K | 0.03% | +19,137+5.3% | Added |
| Adage Capital Partners GP, L.L.C. | 287,900 | $408.8K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 282,782 | $400.0K | 0.00% | +261,060+1,201.8% | Added |
| Two Sigma Investments, LP | 242,960 | $345.0K | 0.00% | +192,027+377.0% | Added |
| Northern Trust Corp | 234,269 | $332.7K | 0.00% | −4,303−1.8% | Reduced |
| Barclays PLC | 196,820 | $279.5K | 0.00% | −47,835−19.6% | Reduced |
| Citadel Advisors LLC | 159,015 | $225.8K | 0.00% | −19,162−10.8% | Reduced |
| Marshall Wace, LLP | 88,691 | $125.9K | 0.00% | +88,691 | New |
| Charles Schwab Investment Management Inc | 85,946 | $122.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 82,300 | $116.9K | 0.00% | −61,250−42.7% | Reduced |
| Two Sigma Advisers, LP | 79,900 | $113.5K | 0.00% | +79,900 | New |
| Marquette Asset Management, LLC | 72,890 | $103.5K | 0.02% | +72,890 | New |
| Goldman Sachs Group Inc | 72,597 | $103.1K | 0.00% | +49,002+207.7% | Added |
| Bank of New York Mellon Corp | 70,940 | $100.7K | 0.00% | +1,701+2.5% | Added |
| Morgan Stanley | 49,440 | $70.2K | 0.00% | −19,137−27.9% | Reduced |
| Dimensional Fund Advisors LP | 38,621 | $54.8K | 0.00% | −120.0% | Reduced |
| Nuveen Asset Management, LLC | 36,322 | $51.6K | 0.00% | 00.0% | Unchanged |
| Cornercap Investment Counsel Inc | 36,157 | $51.3K | 0.01% | 00.0% | Unchanged |
| XTX Topco Ltd | 35,272 | $50.1K | 0.01% | +35,272 | New |
| ADAR1 Capital Management, LLC | 35,000 | $49.7K | 0.01% | +35,000 | New |
| UBS Group AG | 32,749 | $46.5K | 0.00% | +11,659+55.3% | Added |
| Rhumbline Advisers | 27,813 | $39.5K | 0.00% | +900+3.3% | Added |
| Bank of America Corp | 19,226 | $27.3K | 0.00% | −30,756−61.5% | Reduced |
| Prudential Financial Inc | 16,920 | $24.0K | 0.00% | +16,920 | New |
| American International Group, Inc. | 15,255 | $21.7K | 0.00% | −131−0.9% | Reduced |
| New York State Common Retirement Fund | 14,992 | $21.3K | 0.00% | 00.0% | Unchanged |
| Ensign Peak Advisors, Inc | 13,794 | $19.6K | 0.00% | −76,516−84.7% | Reduced |
| JPMorgan Chase & Co | 13,341 | $18.9K | 0.00% | −8,988−40.3% | Reduced |
| SG Americas Securities, LLC | 12,490 | $18.0K | 0.00% | −7,732−38.2% | Reduced |
| Wells Fargo & Company | 10,880 | $15.4K | 0.00% | +1,404+14.8% | Added |
| Invesco Ltd. | 10,158 | $14.4K | 0.00% | 00.0% | Unchanged |
| Atom Investors LP | 10,155 | $14.4K | 0.00% | +10,155 | New |
| Tower Research Capital LLC (TRC) | 8,928 | $12.7K | 0.00% | +3,933+78.7% | Added |
| Citigroup Inc | 5,804 | $8.24K | 0.00% | +1,173+25.3% | Added |
| FMR LLC | 5,801 | $8.24K | 0.00% | −4,178,492−99.9% | Reduced |
| California State Teachers Retirement System | 3,515 | $4.99K | 0.00% | −1,580−31.0% | Reduced |
| Legal & General Group Plc | 2,045 | $2.90K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 1,755 | $2.49K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 707 | $1.00K | 0.00% | −10,204−93.5% | Reduced |
| Amalgamated Bank | 717 | $1.00K | 0.00% | −1,138−61.3% | Reduced |
| Farther Finance Advisors, LLC | 35 | $49 | 0.00% | +35 | New |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 3 | $4 | 0.00% | +3 | New |
| CWM, LLC | 3 | $0 | 0.00% | +3 | New |
| Artal Group S.A. | 0 | $0 | 0.00% | −999,513−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −372,613−100.0% | Sold out |
| Vestal Point Capital, LP | 0 | $0 | 0.00% | −322,671−100.0% | Sold out |
| Vida Ventures Advisors, LLC | 0 | $0 | 0.00% | −225,192−100.0% | Sold out |
| Anson Funds Management LP | 0 | $0 | 0.00% | −209,315−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −26,882−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −22,072−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −20,170−100.0% | Sold out |
| Baystate Wealth Management LLC | – | – | – | – | Not filed |